Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
7.24% $0.0400
America/New_York / 18 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 4.91 mill |
EPS: | -3.13 |
P/E: | -0.0100 |
Earnings Date: | May 13, 2024 |
SharesOutstanding: | 122.68 mill |
Avg Daily Volume: | 17.15 mill |
RATING 2024-04-18 |
---|
B- |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Sell | |
Return On Asset: | Sell | |
DE: | Strong Buy | |
P/E: | Neutral | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.0100 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.00x |
Company: PE -0.0100 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0.0240 - 0.0560 ( +/- 40.00%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-11-29 | Truetzel David W. | Sell | 67 | Common stock |
2020-08-27 | O'brien David Francis | Buy | 269 | Common Stock |
2020-08-25 | O'brien David Francis | Buy | 5 477 | Common Stock |
2015-01-07 | O'brien David Francis | Sell | 7 | Stock Option* |
2014-03-03 | O'brien David Francis | Sell | 10 | Stock Option* |
INSIDER POWER |
---|
-100.00 |
Last 100 transactions |
Buy: 4 995 599 | Sell: 10 978 045 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $0.0400 (7.24% ) |
Volume | 424.42 mill |
Avg. Vol. | 17.15 mill |
% of Avg. Vol | 2 474.22 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.